In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for September 2012, featuring products for manufacturing.

Pharmaceutical Technology
Volume 36, Issue 9, pp. 28

Tablet press expedites changeover times



Fette's FE35 Tablet Press offers one of the fastest changeover times in its class. Its single-rotary design allows the machine to be fitted with up to 51 stations, enabling the production of up to 367,000 tablets per hour. The machine is assembled with detachable, FDA-certified polymer panels and offers 360-degree access. The FE35's direct torque drive offers energy-efficient, zero-maintenance operation. To increase flexibility, a switch cabinet can be positioned internally or externally, and the machine's power cabinet features an innovative cooling design. A fast, easy turret changeover set-up includes cams and punches, and is segmented to permit expedient refitting. Other turret features include a coded tablet scraper and coded filling cam detection, as well as a central, multifunction connector for oil, air, and electricity.

Fette Compacting America
http://www.fette-compacting-america.com/
Product available throughout North America

Aseptic transfer valve



ChargePoint Technology has launched its new aseptic transfer valve, which enables the safe and clean transfer of sensitive product. The design of the valve ensures the integrity of the critical sealing area by achieving a Grade A area within the valve itself. This method eliminates the need for the construction of Grade A areas in new plants and enables aseptic transfers to take place in lower class rooms in existing production areas. The two stage operation firstly involves steam cleaning in place of the active half of the valve, including assurance that the 'ring of concern' is clean. Then, vaporized hydrogen peroxide is introduced into a sealed chamber formed between the discs of the two halves of the valve to ensure that critical sealing faces are decontaminated before the transfer.

ChargePoint Technology
http://www.chargepoint.com/
Product available throughout North America and Europe

Robot-controlled antiswash effect



As the use of robots in pharmaceutical processes increases, swashing of liquid is often an undesired side effect with quick start-and-stop motions. Liquid coating the wall of the vial could adversely affect the freeze drying process. Optima pharma's robot control system keeps the meniscus level, even during quick combinations of lateral and rotational movement. The new, robotic control also inhibits swashing of liquid in the vial.

OPTIMA Packaging Group
http://optima-packaging-group.de
Product available throughout Europe

Wet mill improves API milling capabilities



The Quadro Ytron HV combines inline emulsification and wet mill capabilities in one machine, and offers more than 55 times the high shear energy of conventional rotor–stator systems with precise process scaling from laboratory formulation, to pilot and production processing. Other pharmaceutical applications for the machine include the development of submicron emulsions (high shear homogenizing with a droplet size = 0.2–1 µm), drug suspensions (high shear wet milling with a particle size = 1–10 µm), and topical formulations and semisolids (droplet/particle size = 0.4–3 µm). The HV-Series features three different models ranging from 7.5–60 horsepower with capacities ranging from 1–285 L/min.

Quadro Engineering
http://www.quadro.com/
Product available globally

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here